Company news
Wai Chun Bio-Technology Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
November 2, 2026
Notification of board meeting and continued suspension of trading
October 28, 2026
Supplemental announcement (i) delay in publication of the 2026 annual results; and (ii) continued suspension of trading
October 7, 2026
Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
October 2, 2026
Exchange notice - suspension of trading
October 1, 2026
(I) delay in publication of the 2026 annual results; (ii) possible delay in despatch of the 2026 annual report; and (iii) suspension of trading
October 1, 2026
(I) inside information; (ii) possible delay in publication of the annual results for the year ended 30 June 2026; and (iii) possible suspension of trading
September 22, 2026
Resignation of chief financial officer, company secretary and authorised representative
May 10, 2021
Appointment of chief financial officer, company secretary and authorised representative
May 5, 2021
Resingation of chief financial officcer, company secretary and authorised representative
April 30, 2021
2020 Annual results announcement
April 28, 2021
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 March 2021
April 8, 2021
Delay in publication of the audited results for the year ended 31 December 2020
March 31, 2021
Change of auditor
February 25, 2021
Interim report 2020
September 22, 2020
Wai Chun Bio-Technology: Proposed issue of convertible bonds under specific mandate
September 21, 2020
List of directors and their role and function
September 14, 2020
Resignation of independent non-executive director
September 14, 2020
Cancellation of proposed issue of convertible bonds
September 9, 2020
Change of Company Secretary, Authorised Representative and Chief Financial Officer
August 10, 2020